In additional studies, decreased systemic inflammation and improved survival have been demonstrated in type 1 IFN receptor- and IFNβ-deficient mice during fulminant CLP-induced peritonitis and endotoxin-induced shock, respectively [33-35]. The gene discussed is IFNB1; the disease is peritonitis.